EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial

Tobias Schupp iD, Holger Thiele iD, Tienush Rassaf iD, Amir Abbas Mahabadi, Ralf Lehmann, Ingo Eitel iD, Carsten Skurk, Peter Clemmensen, Marcus Hennersdorf, Ingo Voigt iD, Axel Linke, Eike Tigges und 14 weitere

European Heart Journal: Acute Cardiovascular Care · 2025

DOI: 10.1093/ehjacc/zuae148 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Tobias Schupp und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology, Hemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelb…. Hauptthemen laut MEDLINE: Shock, Cardiogenic, C-Reactive Protein, Myocardial Infarction, Extracorporeal Membrane Oxygenation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Else Kröner Fresenius Foundation, German Heart Research Foundation, Helios Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The impact of systemic inflammation in acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is still a matter of debate. The present ECLS-SHOCK sub-study investigates the association of C-reactive protein (CRP) levels with short-term outcomes in patients with AMI-CS. Methods and results Patients with AMI-CS enrolled in the multicentre, randomized ECLS-SHOCK trial between 2019 and 2022 were included. The prognostic impact of CRP levels on admission, as well as the effect of extracorporeal life support (ECLS), stratified by CRP levels, was tested with regard to the primary endpoint of 30-day all-cause mortality. In 371 patients with AMI-CS and available CRP level on baseline, the median CRP level was 18.0 mg/L. Patients with CRP levels in the highest tertile were older and less often resuscitated from cardiac arrest. The highest tertile (i.e. CRP >61.0 mg/L) was associated with an increased risk of 30-day all-cause mortality compared with patients with lower CRP levels (lowest tertile: ≤5.0 mg/L) [adjusted odds ratio: 3.54; 95% confidence interval (CI) 1.88–6.68; P = 0.001]. The use of ECLS did not reduce 30-day all-cause mortality, irrespective of CRP levels on admission. The additional inclusion of CRP to the IABP-SHOCK II score was associated with a slight improvement of the prediction of 30-days all-cause mortality (area under the curve: 0.74; 95% CI 0.68–0.79).

Conclusion

Higher CRP levels were independently associated with the risk of 30-day all-cause mortality in AMI-CS. The additional inclusion of CRP to a validated CS risk score may further improve the prediction of short-term prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicC-Reactive ProteinMyocardial InfarctionExtracorporeal Membrane OxygenationHumansMaleFemaleAgedPrognosisMiddle AgedBiomarkersSurvival Rate

Stichwörter der Autor:innen

Acute myocardial infarctionC-reactive proteinCardiogenic shockECLSInflammationMortality

Substanzen

C-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Angiology, Hemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
  • Heart Center Leipzig at Leipzig University and Leipzig Heart Science, Leipzig, Germany.
  • Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
  • Asklepios Clinic Langen, Langen, Germany.
  • University Heart Center Lübeck and German Center for Cardiovascular Research, Partner Site Hamburg-Kiel-Lübeck, Lübeck, Germany.
  • Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Benjamin Franklin, Berlin, Germany.

ORCID-Profile: Tobias Schupp, Holger Thiele, Tienush Rassaf, Ingo Eitel, Ingo Voigt, Peter Nordbeck, Christian Jung, Taoufik Ouarrak, Steffen Schneider, Anne Freund, Uwe Zeymer, Ibrahim Akin

Förderung

  • Else Kröner Fresenius Foundation
  • German Heart Research Foundation
  • Helios Health Institute
  • Leipzig Heart Institute
  • Else Kröner Fresenius Foundation

Zitieren

APA

Schupp, T., Thiele, H., Rassaf, T., Mahabadi, A. A., Lehmann, R., Eitel, I., Skurk, C., Clemmensen, P., Hennersdorf, M., Voigt, I., Linke, A., Tigges, E., Nordbeck, P., Jung, C., Lauten, P., Feistritzer, H. J., Buske, M., Pöss, J., Ouarrak, T., …, & Akin, I. (2025). C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuae148

Vancouver

Schupp T, Thiele H, Rassaf T, Mahabadi AA, Lehmann R, Eitel I, et al. C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuae148

BibTeX
@article{Schupp2025,
  author = {Schupp, Tobias and Thiele, Holger and Rassaf, Tienush and Mahabadi, Amir Abbas and Lehmann, Ralf and Eitel, Ingo and Skurk, Carsten and Clemmensen, Peter and Hennersdorf, Marcus and Voigt, Ingo and Linke, Axel and Tigges, Eike and Nordbeck, Peter and Jung, Christian and Lauten, Philipp and Feistritzer, Hans-Josef and Buske, Maria and Pöss, Janine and Ouarrak, Taoufik and Schneider, Steffen and Behnes, Michael and Duerschmied, Daniel and Desch, Steffen and Freund, Anne and Zeymer, Uwe and Akin, Ibrahim},
  title = {C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2025},
  doi = {10.1093/ehjacc/zuae148}
}
Kostenlos starten →